Select a region
Walkers team has advised on the registration of Guernsey's first healthcare cannabinoid investment fund, Verdite Capital Fund I L.P.
The Walkers' team of Partner Kate Storey, Senior Counsel Stephen Ozanne and Associate Adam Pickering represented Chrystal Capital Partners LLP in relation to the registration of the fund, which was registered by the GFSC on 29 July.
Verdite Capital Fund I L.P. will focus on investments in businesses across the legal cannabinoid market worldwide, particularly in North America and Europe. Elysium Fund Management Limited are the designated administrator and Centaur Fund Services Limited in Dublin are the sub-administrator.
A Spokesperson for Walkers said: "The regulatory approval for the fund demonstrates that Guernsey is a leading international financial centre that can provide innovative solutions for novel investment products in an internationally recognised and well regulated jurisdiction."
Pictured top: Walker Partner Kate Storey was part of a team who advised on the registration of the fund.
Comments
Comments on this story express the views of the commentator only, not Bailiwick Publishing. We are unable to guarantee the accuracy of any of those comments.